"Metabolic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Descriptor ID |
D008659
|
| MeSH Number(s) |
C18.452
|
| Concept/Terms |
Metabolic Diseases- Metabolic Diseases
- Thesaurismosis
- Thesaurismoses
- Diseases, Metabolic
- Disease, Metabolic
- Metabolic Disease
|
Below are MeSH descriptors whose meaning is more general than "Metabolic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Metabolic Diseases".
This graph shows the total number of publications written about "Metabolic Diseases" by people in this website by year, and whether "Metabolic Diseases" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 5 | 2 | 7 |
| 2003 | 4 | 2 | 6 |
| 2004 | 5 | 3 | 8 |
| 2005 | 2 | 1 | 3 |
| 2006 | 10 | 1 | 11 |
| 2007 | 9 | 4 | 13 |
| 2008 | 4 | 1 | 5 |
| 2009 | 8 | 2 | 10 |
| 2010 | 7 | 1 | 8 |
| 2011 | 10 | 4 | 14 |
| 2012 | 10 | 7 | 17 |
| 2013 | 14 | 5 | 19 |
| 2014 | 12 | 5 | 17 |
| 2015 | 11 | 4 | 15 |
| 2016 | 8 | 4 | 12 |
| 2017 | 16 | 6 | 22 |
| 2018 | 19 | 7 | 26 |
| 2019 | 16 | 13 | 29 |
| 2020 | 16 | 4 | 20 |
| 2021 | 22 | 5 | 27 |
| 2022 | 9 | 0 | 9 |
| 2023 | 8 | 1 | 9 |
| 2024 | 8 | 4 | 12 |
| 2025 | 0 | 2 | 2 |
Below are the most recent publications written about "Metabolic Diseases" by people in Profiles.
-
Health Effects and Therapeutic Potential of the Gut Microbe Akkermansia muciniphila. Nutrients. 2025 Jan 31; 17(3).
-
Innate immune cells link dietary cues to normal and abnormal metabolic regulation. Nat Immunol. 2025 Jan; 26(1):29-41.
-
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease. Nat Med. 2024 Dec; 30(12):3624-3633.
-
Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders. Mol Metab. 2025 Jan; 91:102065.
-
Assessment of Obesity-related Metabolic Conditions: a novel objective scoring system better informs metabolic disease severity. Surg Obes Relat Dis. 2025 Mar; 21(3):207-215.
-
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases. Metabolism. 2024 Oct; 159:155931.
-
Novel high molecular weight polymerized hemoglobin in a non-obese model of cardiovascular and metabolic dysfunction. Biomed Pharmacother. 2024 Jul; 176:116789.
-
Efficacy and Safety of Fibroblast Growth Factor-21 Analogs for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Meta-Analysis. Clin Pharmacol Ther. 2024 Jul; 116(1):72-81.
-
New and emerging treatments for metabolic dysfunction-associated steatohepatitis. Cell Metab. 2024 May 07; 36(5):912-926.
-
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024 06; 59(12):1521-1526.